{"id":"https://openalex.org/W2104867980","doi":"https://doi.org/10.1093/cid/cit630","title":"Challenges to Conducting a Clinical Trial of Combination Therapy of Colistin and Rifampicin for Extensively Drug-Resistant Acinetobacter baumannii","display_name":"Challenges to Conducting a Clinical Trial of Combination Therapy of Colistin and Rifampicin for Extensively Drug-Resistant Acinetobacter baumannii","publication_year":2013,"publication_date":"2013-09-30","ids":{"openalex":"https://openalex.org/W2104867980","doi":"https://doi.org/10.1093/cid/cit630","mag":"2104867980","pmid":"https://pubmed.ncbi.nlm.nih.gov/24081682"},"language":"en","primary_location":{"id":"doi:10.1093/cid/cit630","doi":"https://doi.org/10.1093/cid/cit630","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cid/cit630","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016570350","display_name":"David B. Huang","orcid":"https://orcid.org/0000-0001-8228-7911","observed_orcids":["https://orcid.org/0000-0001-8228-7911","https://orcid.org/0000-0002-8342-3193"]},"institutions":[{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"D. B. Huang","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark","institution_ids":["https://openalex.org/I4405286694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051107657","display_name":"Mina Pastagia","orcid":"https://orcid.org/0000-0003-4362-2099","observed_orcids":["https://orcid.org/0000-0003-4362-2099"]},"institutions":[{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Pastagia","raw_affiliation_strings":["Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University","2Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University","institution_ids":["https://openalex.org/I83399316"]},{"raw_affiliation_string":"2Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University","institution_ids":["https://openalex.org/I83399316"]}]},{"author_position":"last","author":{"id":null,"display_name":"T. Chiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Chiang","raw_affiliation_strings":["Rutgers New Jersey Medical School, Newark","3Rutgers New Jersey Medical School, Newark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rutgers New Jersey Medical School, Newark","institution_ids":["https://openalex.org/I4402554120"]},{"raw_affiliation_string":"3Rutgers New Jersey Medical School, Newark","institution_ids":["https://openalex.org/I4402554120"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5016570350"],"corresponding_institution_ids":["https://openalex.org/I4405286694"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"58","issue":"1","first_page":"141","last_page":"142"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extensively-drug-resistant-acinetobacter-baumannii","display_name":"extensively drug-resistant Acinetobacter baumannii","score":0.9779999852180481},{"id":"https://openalex.org/keywords/colistin","display_name":"colistin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.9259999990463257},{"id":"https://openalex.org/keywords/30-day-mortality","display_name":"30-day mortality","score":0.9169999957084656},{"id":"https://openalex.org/keywords/confounding-variables","display_name":"confounding variables","score":0.8560000061988831},{"id":"https://openalex.org/keywords/patient-heterogeneity","display_name":"patient heterogeneity","score":0.5049999952316284},{"id":"https://openalex.org/keywords/tigecycline","display_name":"tigecycline","score":0.7590000033378601},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":0.8339999914169312},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/antibiotic-synergy","display_name":"antibiotic synergy","score":0.3269999921321869},{"id":"https://openalex.org/keywords/limitations-of-randomized-controlled-trials","display_name":"randomized controlled trial limitations","score":0.38600000739097595},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.6209999918937683},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.5830000042915344},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.3919999897480011}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8904671669006348},{"id":"https://openalex.org/C2776315533","wikidata":"https://www.wikidata.org/wiki/Q3241189","display_name":"Acinetobacter baumannii","level":4,"score":0.8750978708267212},{"id":"https://openalex.org/C2779259085","wikidata":"https://www.wikidata.org/wiki/Q418946","display_name":"Colistin","level":3,"score":0.8689454197883606},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.7927879691123962},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5361098647117615},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5132986903190613},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.44956374168395996},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4196939468383789},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3894515037536621},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.362934410572052},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3398261070251465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2565974295139313},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.1503305435180664},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.08349010348320007},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06318241357803345},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.058155983686447144},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000151","descriptor_name":"Acinetobacter Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003091","descriptor_name":"Colistin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D024901","descriptor_name":"Drug Resistance, Multiple, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D040981","descriptor_name":"Acinetobacter baumannii","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/cid/cit630","doi":"https://doi.org/10.1093/cid/cit630","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cid/cit630","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:24081682","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24081682","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1984297262","https://openalex.org/W2019351961","https://openalex.org/W2073111603","https://openalex.org/W2124010765","https://openalex.org/W2134377638"],"related_works":["https://openalex.org/W2134377638","https://openalex.org/W2110780462","https://openalex.org/W2103889721","https://openalex.org/W4415687833","https://openalex.org/W2792119757","https://openalex.org/W6920459187","https://openalex.org/W2125965730","https://openalex.org/W2074644957","https://openalex.org/W2123353572","https://openalex.org/W4408865578"],"abstract_inverted_index":{"To":[0],"the":[1,14,25,52,62,118,131],"Editor\u2014We":[2],"commend":[3],"Durante-Mangoni":[4,71],"and":[5,22,61,72],"colleagues":[6,73],"[1]":[7,74],"for":[8,24,39],"conducting":[9],"a":[10,87],"study":[11],"of":[12,17,20,27,51,64,160],"examining":[13],"potential":[15],"role":[16],"combination":[18],"therapy":[19],"colistin":[21,92,100],"rifampicin":[23,102,161],"treatment":[26,112,139],"serious":[28,148],"infections":[29,80],"due":[30,81],"to":[31,67,82,90,117,162],"extensively":[32],"drug-resistant":[33],"(XDR)":[34],"Acinetobacter":[35],"baumannii.":[36],"Identifying":[37],"treatments":[38],"XDR":[40,83,149],"A.":[41,84,150],"baumannii":[42,85,151],"is":[43,155],"an":[44],"obvious":[45],"high":[46],"unmet":[47],"medical":[48],"need":[49],"because":[50],"increased":[53],"mortality":[54,133,154],"rates":[55],"identified":[56],"in":[57],"critically":[58],"ill":[59],"patients":[60,77],"dearth":[63],"antibiotics":[65],"available":[66],"treat":[68],"these":[69],"patients.":[70],"randomized":[75],"210":[76],"with":[78],"life-threatening":[79],"at":[86],"1:1":[88],"ratio":[89],"either":[91],"alone":[93],"(2":[94],"MU":[95],"every":[96,105],"8":[97],"hours)":[98],"or":[99],"plus":[101],"(600":[103],"mg":[104],"12":[106],"hours),":[107],"both":[108],"given":[109],"intravenously.":[110],"The":[111,120,143],"duration":[113],"was":[114,124,134],"left":[115],"up":[116],"investigator.":[119],"primary":[121],"end":[122],"point":[123],"overall":[125],"30-day":[126,132,153],"mortality.":[127],"Results":[128],"indicated":[129],"that":[130,146],"43%,":[135],"without":[136],"difference":[137],"between":[138],"arms":[140],"(P=":[141],".95).":[142],"authors":[144],"conclude":[145],"\u201c[i]n":[147],"infections,":[152],"not":[156],"reduced":[157],"by":[158],"addition":[159],"colistin.\u201d":[163]},"counts_by_year":[{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}